澳大利亚昆士兰州挥发性物质使用后院外心脏骤停的流行病学与生存结局
该研究回顾性分析昆士兰救护车服务2012—2021年接诊的全部院外心脏骤停,其中挥发性物质使用后发生者22例(0.04%),发病率0.04/10万,无时间趋势。最常用产品为除臭剂罐(19/22),中位年龄15岁,男性14/22,原住民8/22。16/22接受急救人员复苏,事件生存率69%、出院生存率38%、神经功能良好生存率31%。使用烃类产品且接受肾上腺素者无一存活出院,未用肾上腺素者6/6存活出院。
要点
- 挥发性物质使用后院外心脏骤停占全部院外心脏骤停的0.04%(22/52,102),发病率0.04/10万,无时间趋势。
- 最常用产品为除臭剂罐(19/22),其次丁烷罐(2/22)、一氧化二氮罐(1/22);中位年龄15岁(IQR 13–23),男性14/22,原住民8/22。
- 接受急救人员复苏的16例中,事件生存率69%(11/16,95%CI 41–89%),出院生存率38%(6/16,95%CI 15–65%),神经功能良好生存率31%(5/16,95%CI 11–59%)。
- 使用烃类产品并接受肾上腺素的8例均未存活出院;未接受肾上腺素的6例均存活出院,其中5/6神经功能良好。
适用人群与场景
- 2012—2021年澳大利亚昆士兰救护车服务接诊的全部院外心脏骤停患者,其中22例发生在挥发性物质使用后。
- 挥发性物质使用后心脏骤停者以青少年为主,中位年龄15岁(IQR 13–23),男性14/22,原住民8/22。
研究设计与关键结果
- 研究类型:回顾性队列分析,数据来自昆士兰救护车服务心脏骤停登记(Utstein-style)并链接医院数据,时间2012—2021年。
- 研究期间共接诊52,102例院外心脏骤停,其中22例(0.04%)发生在挥发性物质使用后;发病率0.04/10万,未发现时间趋势。
- 最常用产品为除臭剂罐(19/22),其次丁烷罐(2/22)、一氧化二氮罐(1/22)。
- 22例中16例接受急救人员复苏;其中12/16为旁观者目击,10/16初始可电击心律,9/16接受旁观者胸外按压。
- 接受复苏的16例中,事件生存率69%(11/16,95%CI 41–89%),出院生存率38%(6/16,95%CI 15–65%),神经功能良好(CPC 1–2)生存率31%(5/16,95%CI 11–59%)。
- 使用烃类产品并接受肾上腺素的8例均未存活出院;未接受肾上腺素的6例均存活出院,其中5/6神经功能良好。
证据类型、等级与局限
- 证据类型:回顾性队列分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,挥发性物质使用后院外心脏骤停罕见且生存率相对较好;患者以青少年为主,原住民比例过高。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: The deliberate inhalation of volatile substances for their psychotropic properties is a recognised public health issue that can precipitate sudden death. This study aimed to describe the epidemiological characteristics and survival outcomes of patients with out-of-hospital cardiac arrests following volatile substance use.
METHODS: We conducted a retrospective cohort analysis of all out-of-hospital cardiac arrest attended by the Queensland Ambulance Service over a ten-year period (2012-2021). Incidents were extracted from the Queensland Ambulance Service cardiac arrest registry, which collects clinical information using the Utstein-style guidelines and linked hospital data.
RESULTS: During the study period, 52,102 out-of-hospital cardiac arrests were attended, with 22 (0.04%) occurring following volatile substance use. The incidence rate was 0.04 per 100,000 population, with no temporal trends identified. The most commonly used product was deodorant cans (19/22), followed by butane canisters (2/22), and nitrous oxide canisters (1/22). The median age of patients was 15 years (interquartile range 13-23), with 14/22 male and 8/22 Indigenous Australians. Overall, 16/22 patients received a resuscitation attempt by paramedics. Of these, 12/16 were bystander witnessed, 10/16 presented in an initial shockable rhythm, and 9/16 received bystander chest compressions. The rates of event survival, survival to hospital discharge, and survival with good neurological outcome (Cerebral Performance Category 1-2) were 69% (11/16, 95% CI 41-89%), 38% (6/16, 95% CI 15-65%) and 31% (5/16, 11-59%), respectively. Eight patients in the paramedic-treated cohort that used hydrocarbon-based products were administered epinephrine during resuscitation. Of these, none subsequently survived to hospital discharge. In contrast, all six patients that did not receive epinephrine survived to hospital discharge, with 5/6 having a good neurological outcome.
CONCLUSION: Out-of-hospital cardiac arrest following volatile substance use is rare and associated with relatively favourable survival rates. Patients were predominately aged in their adolescence with Indigenous Australians disproportionately represented.
参考来源
- Schultz BV, Rolley A, Doan TN, et al. Epidemiology and survival outcomes of out-of-hospital cardiac arrest following volatile substance use in Queensland, Australia. Clin Toxicol (Phila). 2023. PMID: 37988117. doi:10.1080/15563650.2023.2267172
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。